Patents by Inventor Christopher J. GREGG
Christopher J. GREGG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230257724Abstract: Provided herein is a stabilized DNase I polypeptide containing a non-standard amino acid that maintains enzymatic activity even under harsh conditions, such as reducing environments. The stabilized DNase I polypeptide has enzymatic activity in reducing environments that is higher than a corresponding DNase I polypeptide without the non-standard amino acids under the same conditions. Also provided herein are polynucleotides encoding the stabilized DNase I polypeptide, cells for expressing and/or producing the stabilized DNase I polypeptide, and methods of use of the stabilized DNase I polypeptide.Type: ApplicationFiled: January 13, 2023Publication date: August 17, 2023Inventors: Daniel J. Mandell, Christopher J. Gregg, Peter B. Stranges
-
Patent number: 11584921Abstract: Provided herein is a stabilized DNase I polypeptide containing a non-standard amino acid that maintains enzymatic activity even under harsh conditions, such as reducing environments. The stabilized DNase I polypeptide has enzymatic activity in reducing environments that is higher than a corresponding DNase I polypeptide without the non-standard amino acids under the same conditions. Also provided herein are polynucleotides encoding the stabilized DNase I polypeptide, cells for expressing and/or producing the stabilized DNase I polypeptide, and methods of use of the stabilized DNase I polypeptide.Type: GrantFiled: January 8, 2021Date of Patent: February 21, 2023Assignee: GRO Biosciences Inc.Inventors: Daniel J. Mandell, Christopher J. Gregg, Peter B. Stranges
-
Publication number: 20220246240Abstract: Methods and systems for designing, testing, and validating genome designs based on rules or constraints or conditions or parameters or features and scoring are described herein.Type: ApplicationFiled: April 13, 2022Publication date: August 4, 2022Inventors: Gleb Kuznetsov, Marc J. Lajoie, Matthieu M. Landon, Michael G. Napolitano, Daniel Bryan Goodman, Christopher J. Gregg, George M. Church, Nili Ostrov
-
Patent number: 11361845Abstract: Methods and systems for designing, testing, and validating genome designs based on rules or constraints or conditions or parameters or features and scoring are described herein.Type: GrantFiled: June 15, 2017Date of Patent: June 14, 2022Assignee: President and Fellows of Harvard CollegeInventors: Gleb Kuznetsov, Marc J. Lajoie, Matthieu M. Landon, Michael G. Napolitano, Daniel Bryan Goodman, Christopher J. Gregg, George M. Church, Nili Ostrov
-
Publication number: 20210371838Abstract: Provided herein is a stabilized DNase I polypeptide containing a non-standard amino acid that maintains enzymatic activity even under harsh conditions, such as reducing environments. The stabilized DNase I polypeptide has enzymatic activity in reducing environments that is higher than a corresponding DNase I polypeptide without the non-standard amino acids under the same conditions. Also provided herein are polynucleotides encoding the stabilized DNase I polypeptide, cells for expressing and/or producing the stabilized DNase I polypeptide, and methods of use of the stabilized DNase I polypeptide.Type: ApplicationFiled: January 8, 2021Publication date: December 2, 2021Inventors: Daniel J. Mandell, Christopher J. Gregg, Peter B. Stranges
-
Publication number: 20210332350Abstract: A method of altering a target nucleic acid sequence within a cell is provided including providing the cell with a donor nucleic acid, providing the cell with a single strand annealing protein, and providing the cell with a single strand DNA binding protein, wherein one or more or both of the single strand annealing protein and the single strand DNA binding protein is foreign to the cell, and wherein the donor nucleic acid is recombined into the target nucleic acid.Type: ApplicationFiled: February 2, 2017Publication date: October 28, 2021Applicants: President and Fellows of Harvard College, President and Fellows of Harvard CollegeInventors: George M. Church, Christopher J. Gregg, Marc J. Lajoie, Xavier Rios Villanueva
-
Patent number: 10910085Abstract: A method of making a polypeptide including at least one covalent bond between a pair of reactive side chains of corresponding amino acids, wherein the covalent bond is insensitive to reduction is provided including genetically modifying a genomically recoded organism to express a corresponding synthetase, tRNA or synthetase/tRNA pair for translating mRNA encoding the corresponding amino acids having the reactive side chains into the polypeptide and to express the polypeptide including the at least one pair of the reactive side chains wherein the reactive side chains are oriented near one another when the expressed polypeptide is in a folded configuration, wherein the reactive side chains react to form the covalent bond that is insensitive to reduction.Type: GrantFiled: October 28, 2015Date of Patent: February 2, 2021Assignee: President and Fellows of Harvard CollegeInventors: George M. Church, Christopher J. Gregg, Marc J. Lajoie, Daniel J. Mandell
-
Patent number: 10570400Abstract: A method of introducing a nucleic acid sequence into a cell is provided where the cell has impaired or inhibited or disrupted DnaG primase activity or impaired or inhibited or disrupted DnaB helicase activity, or larger or increased gaps or distance between Okazaki fragments or lowered or reduced frequency of Okazaki fragment initiation, or the cell has increased single stranded DNA (ssDNA) on the lagging strand of the replication fork including transforming the cell through recombination with a nucleic acid oligomer.Type: GrantFiled: February 7, 2017Date of Patent: February 25, 2020Assignee: President and Fellows of Harvard CollegeInventors: Marc J. Lajoie, Christopher J. Gregg, Joshua A. Mosberg, George M. Church
-
Publication number: 20200055903Abstract: Methods and systems for designing, testing, and validating genome designs are described herein. A computer-implemented method includes receiving data for a known genome and a list of alleles, identifying and removing occurrences of each allele in the known genome, determining a plurality of allele choices with which to replace occurrences in the known genome, generating a plurality of alternative gene sequences for a genome design based on the known genome, applying a plurality of rules or constraints or conditions or parameters or features to each alternative gene sequence by assigning a score for each rule or constraint or condition or parameter or feature in each alternative gene sequence, resulting in scores, scoring each alternative gene sequence based on a weighted combination of the scores, and selecting at least one alternative gene sequence as the genome design based on the scoring.Type: ApplicationFiled: June 15, 2017Publication date: February 20, 2020Inventors: Gleb Kuznetsov, Marc J. Lajoie, Matthieu M. Landon, Michael G. Napolitano, Daniel Bryan Goodman, Christopher J. Gregg, George M. Church, Nili Ostrov
-
Publication number: 20190194713Abstract: Polypeptides that fold into biologies are stabilized by diselenide bonds between selenocysteine amino acids. Methods to produce such polypeptides in genomically recoded organisms (GRO) can be scaled up for industrial production. Since diselenides have the same geometric bond angles and torsions as disulfides, as well as very similar bond lengths, they can be substituted into polypeptides without disrupting the three dimensional structure of the polypeptides. Diselenides render the polypeptides resistant to reduction when they are exposed to blood serum or to reducing components of blood serum or to reducing components components within cells.Type: ApplicationFiled: August 30, 2017Publication date: June 27, 2019Inventors: Daniel J. MANDELL, Christopher J. GREGG, Ross THYER, Andrew D. ELLINGTON, Peter Benjamin STRANGES
-
Publication number: 20170337323Abstract: A method of making a polypeptide including at least one covalent bond between a pair of reactive side chains of corresponding amino acids, wherein the covalent bond is insensitive to reduction is provided including genetically modifying a genomically recoded organism to express a corresponding synthetase, tRNA or synthetase/tRNA pair for translating mRNA encoding the corresponding amino acids having the reactive side chains into the polypeptide and to express the polypeptide including the at least one pair of the reactive side chains wherein the reactive side chains are oriented near one another when the expressed polypeptide is in a folded configuration, wherein the reactive side chains react to form the covalent bond that is insensitive to reduction.Type: ApplicationFiled: October 28, 2015Publication date: November 23, 2017Inventors: George M. Church, Christopher J. Gregg, Marc J. Lajoie, Daniel J. Mandell
-
Publication number: 20170183666Abstract: A method of introducing a nucleic acid sequence into a cell is provided where the cell has impaired or inhibited or disrupted primase activity or impaired or inhibited or disrupted helicase activity, or larger or increased gaps or distance between Okazaki fragments or lowered or reduced frequency of Okazaki fragment initiation, or the cell has increased single stranded DNA (ssDNA) on the lagging strand of the replication fork including transforming the cell through recombination with a nucleic acid oligomer.Type: ApplicationFiled: February 7, 2017Publication date: June 29, 2017Inventors: Marc J. Lajoie, Christopher J. Gregg, Joshua A. Mosberg, George M. Church
-
Patent number: 9688994Abstract: A method of introducing a nucleic acid sequence into a cell is provided where the cell has impaired or inhibited or disrupted DnaG primase activity or impaired or inhibited or disrupted DnaB helicase activity, or larger or increased gaps or distance between Okazaki fragments or lowered or reduced frequency of Okazaki fragment initiation, or the cell has increased single stranded DNA (ssDNA) on the lagging strand of the replication fork including transforming the cell through recombination with a nucleic acid oligomer.Type: GrantFiled: July 30, 2013Date of Patent: June 27, 2017Assignee: President and Fellows of Harvard CollegeInventors: Marc J. Lajoie, Christopher J. Gregg, Joshua A. Mosberg, George M. Church
-
Publication number: 20140315829Abstract: The invention relates to compositions and methods for increasing sialic acid uptake and/or incorporation into tissue following gastrointestinal ingestion of compositions that contain sialic acid.Type: ApplicationFiled: July 2, 2014Publication date: October 23, 2014Inventors: Ajit Varki, Kalyan Banda, Christopher J. Gregg
-
Publication number: 20140057856Abstract: The invention relates to compositions and methods for increasing sialic acid uptake and/or incorporation into tissue following gastrointestinal ingestion of compositions that contain sialic acid.Type: ApplicationFiled: August 22, 2013Publication date: February 27, 2014Applicant: The Regents of The Universtiy of CaliforniaInventors: Ajit Varki, Kalyan Banda, Christopher J. Gregg
-
Publication number: 20140045267Abstract: A method of introducing a nucleic acid sequence into a cell is provided where the cell has impaired or inhibited or disrupted primase activity or impaired or inhibited or disrupted helicase activity, or larger or increased gaps or distance between Okazaki fragments or lowered or reduced frequency of Okazaki fragment initiation, or the cell has increased single stranded DNA (ssDNA) on the lagging strand of the replication fork including transforming the cell through recombination with a nucleic acid oligomer. The present invention relates to methods of introducing one or more nucleic acid sequences into a cell having impaired or inhibited or disrupted primase activity or impaired or inhibited or disrupted helicase activity, or larger or increased gaps or distance between Okazaki fragments or lowered or reduced frequency of Okazaki fragment initiation.Type: ApplicationFiled: July 30, 2013Publication date: February 13, 2014Applicant: PRESIDENT AND FELLOWS OF HARVARD COLLEGEInventors: Marc J. LAJOIE, Christopher J. GREGG, Joshua A. MOSBERG, George M. CHURCH